CAS 1803274-65-8

BAY-1436032

CAS : 1803274-65-8

Formule : C₂₆H₃₀F₃N₃O₃

Degré de pureté : 98%

Masse moléculaire : 489.5299

Ref: IN-DA00AMHD

BAY-1436032

CAS : 1803274-65-8

BAY-1436032

Degré de pureté : ≥98%

Masse moléculaire : 489.53g/mol

Ref: 54-BUP16305

BAY-1436032

CAS : 1803274-65-8

BAY-1436032 is a novel, selective and orally available inhibitor of pan-mutant isocitrate dehydrogenase 1 (IDH1).

Formule : C₂₆H₃₀F₃N₃O₃

Degré de pureté : 99.65% - 99.71%

Couleur et forme : Solid

Masse moléculaire : 489.53

Ref: TM-TQ0042

BAY-1436032

CAS : 1803274-65-8

BAY-1436032 is a novel small molecule inhibitor of CXCR4. It has been shown to be an effective treatment for cancer in vitro, with potent inhibition of cancer cell growth and anti-leukemic activity. BAY-1436032 is orally bioavailable and has good pharmacokinetic properties. It binds specifically to the CXCR4 receptor, blocking the binding of stromal cell-derived factor 1α (SDF1α) and its chemokine ligand 4 (CXCL4). This drug has also been shown to inhibit the proliferation of leukemia stem cells in vitro and in vivo, as well as suppressing sarcoma cell growth.

Formule : C₂₆H₃₀F₃N₃O₃

Degré de pureté : Min. 95%

Masse moléculaire : 489.53 g/mol

Ref: 3D-DXC27465